Akzo Nobel NV

Latest Results (24.10.2025):

Akzo Nobel NV reported its financial results for the second quarter of 2025, showing mixed performance with flat organic sales and a 6% decline in revenue due to adverse currency impacts. Operating income and Adjusted EBITDA decreased compared to the same period last year, primarily influenced by restructuring costs. However, the company achieved a slight expansion in its Adjusted EBITDA margin driven by efficiency measures.

Revenue Performance

In Q2 2025, Akzo Nobel NV reported total revenue of €5,239 million, a 3% decrease compared to €5,424 million in Q2 2024. The decline was primarily due to a 6% reduction in revenue driven by adverse currency effects, despite organic sales remaining flat and prices increasing by 2%.

Operating Income

The operating income for Q2 2025 stood at €214 million, down 21% from €270 million in the same quarter last year. The decrease was mainly attributed to restructuring costs incurred during the period.

Adjusted EBITDA

Adjusted EBITDA for Q2 2025 was €393 million, reflecting a 6% decrease from €400 million in Q2 2024. The Adjusted EBITDA margin improved slightly to 15.0% from 14.4%, supported by efficiency actions implemented by the company.

Net Cash from Operating Activities

Net cash from operating activities increased to €234 million in Q2 2025, up from €151 million in Q2 2024. This improvement was driven by stronger operational cash flow despite the decline in revenue.

Outlook

Akzo Nobel NV maintains its full-year 2025 guidance, expecting to achieve an Adjusted EBITDA above €1.48 billion, subject to ongoing market uncertainties. The company continues to focus on expanding profitability and maintaining a strong investment-grade credit rating.